Science
Mechanism of Action
This extract operates by interrupting the MAPK and NF-κB signaling cascades, effectively downregulating the production of pro-inflammatory mediators such as iNOS and COX-2. By suppressing cytokines like IL-6 and TNF-α, it stops inflammatory stress at the molecular level while simultaneously providing antioxidant defense and inhibiting tyrosinase-driven melanogenesis.
Research
Clinical Evidence
High confidence3%
Key findings
- 01 Clinical observations of Artemisia species demonstrate a 21.5% reduction in transepidermal water loss (TEWL) and a 77.5% decrease in sensitized skin area over 28 days.
- 02 In vitro studies show that isolated lignans (aschantin) at 10 μM significantly inhibit Nitric Oxide and pro-inflammatory cytokine production in stimulated cells.
Transparency
Dusting Analysis
While many brands include Artemisia for marketing appeal at concentrations below 0.5%, clinical data suggests a minimum threshold of 1% is required to achieve measurable improvements in barrier repair and sensitivity reduction.
The Formula
Formulation
Stability
Highly heat-sensitive; must be incorporated during the cool-down phase at temperatures below 40°C to maintain the integrity of volatile bioactive compounds and lignans.
Synergies
- Ceramides
- Hyaluronic Acid
- Centella Asiatica
Conflicts
- Strong oxidizers
- Extreme alkaline environments
Safety
Safety Profile
Recognized as safe for skin conditioning in the EU CosIng database. While stable up to 30% in specialized formulations, commercial efficacy is typically optimized between 1% and 5%.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An exceptional soothing agent for modern skincare, providing verified molecular-level reduction in inflammation and significant barrier reinforcement.
Related
Similar Ingredients
Finding similar ingredients…